APA (7th ed.) Citation

Krikke, M., Hoogeveen, R., Hoepelman, A., Visseren, F., & Arends, J. (2016). Cardiovascular risk prediction in HIV-infected patients: Comparing the Framingham, atherosclerotic cardiovascular disease risk score ( ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE -NL) and Data Collection on Adverse Events of Anti- HIV Drugs ( D: A: D) risk prediction models. HIV Medicine, 17(4), 289. https://doi.org/10.1111/hiv.12300

Chicago Style (17th ed.) Citation

Krikke, M., RC Hoogeveen, AIM Hoepelman, FLJ Visseren, and JE Arends. "Cardiovascular Risk Prediction in HIV-infected Patients: Comparing the Framingham, Atherosclerotic Cardiovascular Disease Risk Score ( ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE -NL) and Data Collection on Adverse Events of Anti- HIV Drugs ( D: A: D) Risk Prediction Models." HIV Medicine 17, no. 4 (2016): 289. https://doi.org/10.1111/hiv.12300.

MLA (9th ed.) Citation

Krikke, M., et al. "Cardiovascular Risk Prediction in HIV-infected Patients: Comparing the Framingham, Atherosclerotic Cardiovascular Disease Risk Score ( ASCVD), Systematic Coronary Risk Evaluation for the Netherlands (SCORE -NL) and Data Collection on Adverse Events of Anti- HIV Drugs ( D: A: D) Risk Prediction Models." HIV Medicine, vol. 17, no. 4, 2016, p. 289, https://doi.org/10.1111/hiv.12300.